Total Payments
$1,587
2024 Payments
$198.46
Companies
15
Transactions
83
Payment Breakdown by Category
Food & Beverage$1,587 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,587 | 83 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $482.38 | 30 | $0 (2024) |
| Indivior Inc. | $240.26 | 8 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $160.82 | 9 | $0 (2021) |
| Collegium Pharmaceutical, Inc. | $134.16 | 7 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $125.45 | 7 | $0 (2023) |
| Gilead Sciences, Inc. | $97.56 | 4 | $0 (2023) |
| Braeburn Inc. | $88.60 | 4 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $58.43 | 4 | $0 (2022) |
| PFIZER INC. | $46.51 | 3 | $0 (2023) |
| Forte Bio-Pharma LLC | $34.09 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $198.46 | 10 | Braeburn Inc. ($88.60) |
| 2023 | $528.15 | 29 | ABBVIE INC. ($152.83) |
| 2022 | $516.09 | 25 | ABBVIE INC. ($267.60) |
| 2021 | $343.84 | 19 | Biohaven Pharmaceuticals, Inc. ($160.82) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: Opioid Use Disorder | ||||||
| 11/26/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Endocrinology | ||||||
| 11/19/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: OUD | ||||||
| 09/17/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: OUD | ||||||
| 09/06/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Opioid Use Disorder | ||||||
| 07/25/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $18.11 | General |
| Category: Opioid Analgesic | ||||||
| 06/20/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Opioid Use Disorder | ||||||
| 04/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: NEUROSCIENCE | ||||||
| 02/29/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Opioid Use Disorder | ||||||
| 01/16/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: VIROLOGY | ||||||
| 12/18/2023 | Pacira Pharmaceuticals Incorporated | Exparel (Drug), Iovera, Zilretta | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: Pain Management | ||||||
| 12/04/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: VIROLOGY | ||||||
| 11/30/2023 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: OUD | ||||||
| 11/14/2023 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $33.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.74 | General |
| 10/26/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: VIROLOGY | ||||||
| 10/24/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: PSYCHIATRY | ||||||
| 09/18/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: VIROLOGY | ||||||
| 09/13/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: VIROLOGY | ||||||
| 09/07/2023 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: HCV | ||||||
| 09/05/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: PSYCHIATRY | ||||||
| 08/10/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: VIROLOGY | ||||||
| 08/04/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: NEUROSCIENCE | ||||||
| 07/13/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.71 | General |
| 07/11/2023 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: PAIN | ||||||
About Thomas King, FNP
Thomas King, FNP is a Critical Care Medicine healthcare provider based in Jamestown, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/19/2012. The National Provider Identifier (NPI) number assigned to this provider is 1497005268.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Thomas King, FNP has received a total of $1,587 in payments from pharmaceutical and medical device companies, with $198.46 received in 2024. These payments were reported across 83 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,587).
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pain Management, Nurse Practitioner
- Location Jamestown, CA
- Active Since 09/19/2012
- Last Updated 08/25/2025
- Taxonomy Code 163WC0200X
- Entity Type Individual
- NPI Number 1497005268
Products in Payments
- UBRELVY (Drug) $265.12
- SUBLOCADE (Drug) $240.26
- NURTEC ODT (Drug) $219.25
- QULIPTA (Drug) $124.05
- XTAMPZA (Drug) $116.05
- REXULTI (Drug) $107.69
- MAVYRET (Drug) $93.21
- BRIXADI (Drug) $88.60
- NALOCET (Drug) $34.09
- PROKERA (Device) $34.01
- COMIRNATY (Biological) $29.84
- Exparel (Drug) $27.96
- Epclusa (Drug) $27.13
- Korlym (Drug) $21.70
- Belbuca (Drug) $18.11
- QUVIVIQ (Drug) $18.10
- ABILIFY MAINTENA (Drug) $17.76
- PAXLOVID (Drug) $16.67
- Wegovy (Drug) $16.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.